Kure Therapeutics logo

Kure Therapeutics Share Price (NASDAQ: OKUR)

$2.8

Live

Last updated on

Check the interactive Kure Therapeutics Stock chart to analyse performance

Kure Therapeutics Inc Key Stats

Check Kure Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.8
Open
$2.75
Market Capitalization
$37.2M
Today's Volume
$90.8K
Revenue TTM
$0.0
EBITDA
$-62.8M
Earnings Per Share (EPS)
$-4.46
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-142.9%

Stock Returns calculator for Kure Therapeutics Stock including INR - Dollar returns

The Kure Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Kure Therapeutics investment value today

Current value as on today

₹23,538

Returns

₹76,462

(-76.46%)

Returns from Kure Therapeutics Stock

₹80,822 (-80.82%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Kure Therapeutics Stock

200%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Kure Therapeutics Stock from India on INDmoney has increased by 200% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Kure Therapeutics Stock

Rating
Trend

Kure Therapeutics Share Price Target

What analysts predicted

Upside of 971.43%

Target:

$30.00

Current:

$2.80

Kure Therapeutics share price target is $30.00, a slight Upside of 971.43% compared to current price of $2.80 as per analysts' prediction.

Kure Therapeutics Stock Insights

  • Price Movement

    In the last 1 month, OKUR stock has moved up by 22.8%
  • OKUR vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 142.6%
  • OKUR vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 115.3% return, outperforming this stock by 206.8%

Kure Therapeutics Technicals Summary

Sell

Neutral

Buy

Kure Therapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Kure Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Kure Therapeutics Inc logo
23.89%
-42.74%
-80.82%
-91.41%
-97.98%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Kure Therapeutics Inc

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
Organization
Kure Therapeutics
Employees
46
CEO
Dr. Nicholas A. Saccomano Ph.D.
Industry
Miscellaneous

Key Management of Kure Therapeutics Inc

NameTitle
Dr. Nicholas A. Saccomano Ph.D.
President, CEO & Director
Mr. Jason A. Leverone CPA
Chief Financial Officer
Dr. Samuel Agresta M.D., M.P.H.
Chief Medical Officer
Dr. Dylan Hartley Ph.D.
Chief Scientific Officer
Mr. Rogan P. Nunn J.D.
General Counsel & Secretary
Dr. James Blake Ph.D.
Senior Vice President of Computational Drug Discovery
Dr. Kevin S. Litwiler Ph.D.
Senior Vice President of DMPK & Clinical Pharmacology
Dr. Mark L. Boys Ph.D.
Senior Vice President of Discovery Chemistry
Ms. Roberta Alton
Senior VP of Clinical Operations

Important FAQs about investing in OKUR Stock from India :

What is Kure Therapeutics share price today?

Kure Therapeutics share price today is $2.80 as on . Kure Therapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Kure Therapeutics share?

Kure Therapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Kure Therapeutics stock price today i.e. is trending at $2.80, lower by 86% versus the 52 week high.

How to invest in Kure Therapeutics Stock (OKUR) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Kure Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kure Therapeutics Shares that will get you 0.5357 shares as per Kure Therapeutics share price of $2.80 per share as on August 28, 2025 at 11:38 pm IST.

What is the minimum amount required to buy Kure Therapeutics Stock (OKUR) from India?

Indian investors can start investing in Kure Therapeutics (OKUR) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Kure Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Kure Therapeutics share’s latest price of $2.80 as on August 28, 2025 at 11:38 pm IST, you will get 3.5714 shares of Kure Therapeutics. Learn more about fractional shares .

What are the returns that Kure Therapeutics has given to Indian investors in the last 5 years?

Kure Therapeutics stock has given -97.98% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?